Citius Pharmaceuticals (CTXR) Financials

$0.60

$0.01 (2.13%)

As on 08-Sep-2026 16:05EDT

Market cap

$16 Mln

Revenue (TTM)

$7 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Operating Revenue	7.11	--	--	--	--	--
Cost of Revenue	5.69	0.21	0.21	0.19	0.18	0.16
Gross Profit	1.42	-0.21	-0.21	-0.19	-0.18	-0.16
Operating Expenses	62.80	38.31	42.00	36.73	33.32	23.37
Operating Profit (EBIT)	-61.38	-38.53	-42.00	-36.73	-33.32	-23.53
Other Income	--	--	--	--	--	0.49
Profit before Tax	-57.98	-38.68	-38.85	-31.97	-33.06	-23.05
Provision for Tax	0.19	1.06	0.58	0.58	0.58	0.07
Profit after Tax (Net Income)	-46.27	-37.43	-39.14	-32.54	-33.64	-23.05
Minority Interest	11.89	2.31	0.29	--	--	--
Consolidated Profit	--	--	--	--	-33.64	-24.51

Liabilities ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Shareholder's Funds	66.61	67.55	70.08	90.83	102.83	132.18
Minority Interest	11.89	--	--	--	0.60	0.60
Non-Current Liabilities	14.70	8.50	6.74	6.40	6.04	5.66
Current Liabilities	51.65	44.91	35.81	5.78	4.53	3.98
Total Liabilities	193.90	130.94	116.65	103.61	114.00	142.43

Assets ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Non-Current Assets	98.92	103.00	102.43	69.24	69.44	69.61
Current Assets	43.33	27.93	14.22	34.37	44.56	72.81
Total Assets	193.90	130.94	116.65	103.61	114.00	142.43
Total Debt*	7.18	1.81	0.26	0.48	0.68	0.86
Net Current Assets	-8.32	-16.98	-21.59	28.59	40.03	68.83

Cashflow ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Cash From Operating Activities	--	-26.55	-28.20	-29.06	-28.36	-24.25
Cash Flow from Investing Activities	--	-5.75	-5.00	--	--	-40.01
Cash from Financing Activities	--	33.30	9.97	13.83	0.03	120.47
Net Cash Inflow / Outflow	--	--	--	--	-28.36	56.21

Financials Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Adjusted EPS ($)	-2.11	-2.07	-3.38	-3.07	-0.23	-3.95
Cash EPS ($)	--	-2.06	-3.36	-3.05	-0.23	-3.92
Adjusted Book Value ($)	--	3.74	6.05	8.58	0.70	22.64
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.47	-2.43	-2.74	-0.19	-4.15
Free Cash Flow per Share ($)	--	-1.47	-2.43	-2.74	-0.19	-11.00

Profitability Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
ROCE (%)	--	-53.59	-48.42	-33.41	-28.44	-27.44
ROE (%)	-46.91	-54.40	-48.65	-33.61	-28.63	-27.80
ROA (%)	-24.78	-30.24	-35.54	-29.91	-26.24	-24.76
EBIT Margin (%)	-863.17	--	--	--	--	--
Net Margin (%)	-651.27	--	--	--	--	-4,721.38
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Revenue Growth (%)	2,178.39	--	--	--	--	--
EBIT Growth (%)	-49.29	1.12	-5.77	-10.25	-41.58	-32.87
Net Profit Growth (%)	11.26	4.36	-20.27	3.26	-45.92	-31.38
EPS Growth (%)	39.94	0.39	-0.10	-12.36	0.94	0.41
Book Value Growth (%)	-56.94	--	--	--	--	--

Valuation Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Price / Earnings	--	-0.60	-0.15	-0.22	-5.26	-0.51
Price / Book Value	0.23	0.33	0.08	0.08	1.72	0.09
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.74	-0.52	-0.07	0.51	-4.10	2.45
Close Price ($)	0.60	1.24	12.52	17.10	30.25	50.75
High Price ($)	2.48	12.84	26.75	42.75	56.25	114.00
Low Price ($)	0.48	0.65	12.00	15.75	20.77	21.82
Market Cap ($ Cr)	16.13	--	--	--	--	--

Solvency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debt to Equity	0.10	0.03	0.00	0.01	0.01	0.01
Short term debt to equity ratio	0.00	0.02	0.00	0.00	0.00	0.00
Current Ratio	0.84	0.62	0.40	5.95	9.84	18.28
Quick Ratio	0.40	0.13	0.17	5.95	--	--
Interest Coverage	-82.38	-143.46	--	--	-132.52	-2,171.04

Operating Efficiency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debtors to sales (%)	9.66	--	--	--	--	--
Asset Turnover	0.04	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	26,045.23	7,204.22	--	--	--
Payable days	--	15,872.31	6,843.33	3,846.47	2,482.55	3,470.80
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.